Pancreatic Cancer Research

ResearcherKagoshima UniversityNo recent work listed

Takashi Yoshiura

Matched on ORCID iD 0000-0003-2918-4336; OpenAlex author ID A5101450916. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 11)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2016: 2 papers · 2017: 3 papers · 2018: none · 2019: 2 papers · 2020: 2 papers · 2021: 2 papers · 2022: 1 paper

Papers 12

  1. Value of Dual-Energy Computed Tomography for Detecting Small Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1097/mpa.0000000000002207↗
  2. Extracellular volume fraction with MRI: As an alternative predictive biomarker to dynamic contrast-enhanced MRI for chemotherapy response of pancreatic ductal … Last author DOI 10.1016/j.ejrad.2021.110036↗
  3. Adding Delayed Phase Images to Dual-Phase Contrast-Enhanced CT Increases Sensitivity for Small Pancreatic Ductal Adenocarcinoma. Last author DOI 10.2214/ajr.20.25430↗
  4. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal ade… Last author DOI 10.1007/s00330-019-06517-w↗
  5. Visual enhancement pattern during the delayed phase of enhanced CT as an independent prognostic factor in stage IV pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.pan.2020.07.009↗
  6. Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic a… Last author DOI 10.1007/s00330-018-5570-4↗
  7. Estimation of Extracellular Volume Fraction With Routine Multiphasic Pancreatic Computed Tomography to Predict the Survival of Patients With Stage IV Pancreati… Last author DOI 10.1097/mpa.0000000000001427↗
  8. A pilot study of the diagnostic and prognostic values of FLT-PET/CT for pancreatic cancer: comparison with FDG-PET/CT. Last author DOI 10.1007/s00261-016-0987-1↗
  9. Computed diffusion-weighted MR imaging for visualization of pancreatic adenocarcinoma: Comparison with acquired diffusion-weighted imaging. Last author DOI 10.1016/j.ejrad.2017.07.022↗
  10. Comparison of proton beam radiotherapy and hyper-fractionated accelerated chemoradiotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2017.07.191↗
  11. Diffusion-weighted MR imaging of the pancreas: optimizing b-value for visualization of pancreatic adenocarcinoma. Last author DOI 10.1007/s00330-015-4174-5↗
  12. Histogram Analysis of Apparent Diffusion Coefficient in Differentiating Pancreatic Adenocarcinoma and Neuroendocrine Tumor. Last author DOI 10.1097/md.0000000000002574↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoshihiko Fukukura · 11 shared papers, 2016–2022 · strength 1.10
  2. Kosei Maemura · 5 shared papers, 2017–2020 · strength 0.48
  3. Yosuke Fujisaki · 3 shared papers, 2021–2022 · strength 0.42
  4. Shinya Nakamura · 3 shared papers, 2021–2022 · strength 0.42
  5. Shiho Arima · 3 shared papers, 2019–2020 · strength 0.33
  6. Masatoyo Nakajo · 3 shared papers, 2017–2020 · strength 0.29
  7. Hiroaki Nagano · 2 shared papers, 2020–2021 · strength 0.23
  8. Hiroshi Kurahara · 2 shared papers, 2017–2022 · strength 0.21
  9. Toshikazu Shindo · 3 shared papers, 2016–2017 · strength 0.18
  10. Shinichi Hashimoto · 1 shared paper, 2022 · strength 0.15
  11. Dominik Marcel Nickel · 1 shared paper, 2021 · strength 0.15
  12. Michiyo Higashi · 1 shared paper, 2019 · strength 0.09
  13. Masayuki Nakajo · 1 shared paper, 2017 · strength 0.07
  14. Shoji Natsugoe · 1 shared paper, 2017 · strength 0.06
  15. Yuko Mataki · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.